{"id":44662,"date":"2022-06-03T14:01:49","date_gmt":"2022-06-03T12:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/"},"modified":"2022-06-03T14:01:49","modified_gmt":"2022-06-03T12:01:49","slug":"bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/","title":{"rendered":"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting"},"content":{"rendered":"
\n

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that three abstracts have been accepted for poster presentations and one abstract has been accepted for online publication for the 2022 ASCO Annual Meeting (ASCO), which will be held June 3 \u2013 7, 2022, at McCormick Place Convention Center in Chicago, IL. BostonGene will also exhibit at booth 27087.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are excited to share our latest research at ASCO that underscores the critical need for innovative analytical tools to understand the composition and activity of the tumor and the microenvironment to improve treatment outcomes for cancer patients,\u201d said Nathan Fowler MD, Chief Medical Officer at BostonGene.\n<\/p>\n

\nDetails about the abstracts selected for presentation can be found below:\n<\/p>\n

\nAbstract Number: <\/b>4591
\n
Title:<\/b> <\/i>A classification system for urothelial carcinoma (UC) defined by genomic drivers and the tumor microenvironment (TME) is predictive of immunotherapy response<\/a>
Date and Time: <\/b>Saturday, June 4 | 1:15 PM \u2013 4:15 PM
\n
Location:<\/b> McCormick Place Convention Center, Hall A
\n
Poster Number:<\/b> 82
\n
Speaker: <\/b>Krystle Nomie, PhD, BostonGene<\/i>\n<\/p>\n

\nThis presentation underscores the application of BostonGene\u2019s transcriptome-based classification platform, previously reported by Bagaev et al., to identify TME subtypes for urothelial carcinoma that are predictive of response to immunotherapy.\n<\/p>\n

\nAbstract Number: <\/strong>3020
<\/span>Title: <\/strong>A clinical AI-driven multiplex immunofluorescence imaging pipeline to characterize tumor microenvironment heterogeneity<\/a>
Date and Time<\/b>: Sunday, June 5 | 8:00 AM \u2013 11:00 AM*
\n
Location:<\/b> McCormick Place Convention Center, Hall A
\n
Poster Number:<\/b> 12
\n
Speaker: <\/b>Zhongmin Xiang, PhD, BostonGene<\/i>\n<\/p>\n

\n*A follow-up poster discussion highlighting the AI-driven BostonGene MxIF analytical pipeline and its automated microenvironment characterization across cancers will take place from 4:30 PM \u2013 6:00 PM in Hall D2<\/i>\n<\/p>\n

\nThis presentation highlights the importance of innovative MxIF platforms to characterize tumor heterogeneity at single-cell resolution with high accuracy across many cancers.\n<\/p>\n

\nAbstract Number: <\/b>3142
\n
Title: <\/b>A digital imaging analysis (DIA) platform for identifying tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD)<\/a>
Date and Time: <\/b>Sunday, June 5 | 8:00 AM \u2013 11:00 AM
\n
Location:<\/b> McCormick Place Convention Center, Hall A
\n
Poster Number:<\/b> 134
\n
Speaker: <\/b>Ekaterina Postovalova, PhD, BostonGene<\/i>\n<\/p>\n

\nThis presentation demonstrates the ability of novel and cutting-edge imaging technologies in the BostonGene pipeline to detect tertiary lymphoid structures (TLS) in lung cancer.\n<\/p>\n

\nOnline publication abstract:\n<\/p>\n

\nAbstract Number: <\/b>e20624
\n
Title: <\/b>Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma\n<\/p>\n

\nThis abstract highlights the importance of a longitudinal comprehensive molecular analysis using genomic and transcriptomic sequencing to improve the understanding of rare thymic epithelial tumors.\n<\/p>\n

\nResearch conducted with Massachusetts General Hospital<\/i>\n<\/p>\n

\nFor more information, please visit the 2022 ASCO Annual Meeting website<\/a>. The abstracts will be published online in the Journal of Clinical Oncology<\/i> supplement for the ASCO Annual Meeting Proceedings.\n<\/p>\n

\nAbout BostonGene Corporation<\/b>\n<\/p>\n

\nBostonGene\u2019s mission is to power healthcare\u2019s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. BostonGene Tumor PortraitTM<\/sup> Tests <\/sup>reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene Tumor PortraitTM<\/sup> Tests generate a personalized roadmap for therapeutic decision-making for each cancer patient. For more information, visit BostonGene at http:\/\/www.BostonGene.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
BostonGene<\/b>
Erin O\u2019Reilly
\n
+1-781-366-7049
\n
Erin.Oreilly@BostonGene.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that three abstracts have been accepted for poster presentations and one abstract has been accepted for online publication for the 2022 ASCO Annual Meeting (ASCO), which will be held June 3 \u2013 7, 2022, at McCormick Place Convention Center in Chicago, IL. BostonGene will also exhibit at booth 27087. \u201cWe … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44662","6":"format-standard","7":"category-industry"},"yoast_head":"\nBostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that three abstracts have been accepted for poster presentations and one abstract has been accepted for online publication for the 2022 ASCO Annual Meeting (ASCO), which will be held June 3 \u2013 7, 2022, at McCormick Place Convention Center in Chicago, IL. BostonGene will also exhibit at booth 27087. \u201cWe ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-03T12:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220601005073\/en\/821014\/21\/bostongene-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting\",\"datePublished\":\"2022-06-03T12:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/\"},\"wordCount\":532,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005073\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/\",\"name\":\"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005073\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\",\"datePublished\":\"2022-06-03T12:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005073\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005073\\\/en\\\/821014\\\/21\\\/bostongene-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting - Pharma Trend","og_description":"WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that three abstracts have been accepted for poster presentations and one abstract has been accepted for online publication for the 2022 ASCO Annual Meeting (ASCO), which will be held June 3 \u2013 7, 2022, at McCormick Place Convention Center in Chicago, IL. BostonGene will also exhibit at booth 27087. \u201cWe ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-03T12:01:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220601005073\/en\/821014\/21\/bostongene-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting","datePublished":"2022-06-03T12:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/"},"wordCount":532,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601005073\/en\/821014\/21\/bostongene-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/","name":"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601005073\/en\/821014\/21\/bostongene-logo.jpg","datePublished":"2022-06-03T12:01:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220601005073\/en\/821014\/21\/bostongene-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220601005073\/en\/821014\/21\/bostongene-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bostongene-to-present-at-the-2022-american-society-of-clinical-oncology-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44662"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44662\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}